Cover Image
市場調查報告書

全球眼科用醫藥品及設備市場:各國 (美國、加拿大、印度、中國、日本、英國) 、企業簡介、佔有率、趨勢、分析、機會、市場區隔,及2015∼2021年的預測

Global Ophthalmology Drugs and Devices Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 348147
出版日期 內容資訊 英文 140 Pages
商品交期: 請詢問到貨日
價格
Back to Top
全球眼科用醫藥品及設備市場:各國 (美國、加拿大、印度、中國、日本、英國) 、企業簡介、佔有率、趨勢、分析、機會、市場區隔,及2015∼2021年的預測 Global Ophthalmology Drugs and Devices Market, By Country (United States, Canada, India, China, Japan, United Kingdom), Company Profiles, Share, Trends, Analysis, Opportunities, Segmentation And Forecast 2015 - 2021
出版日期: 2016年01月01日 內容資訊: 英文 140 Pages
簡介

全球眼科用醫藥品及設備市場,預計2015∼2021年以7%的年複合成長率擴大。該市場由於青光眼和白內障等眼科疾病的罹患率上升和新藥及設備的法律規章的認證,微創設備等新技術的登場等而擴大。

本報告提供與全球眼科用醫藥品及設備市場相關調查、市場概要到至2021年的成長預測、產業趨勢、各地區、各市場區隔趨勢,及以及主要企業的簡介等彙整。

第1章 歷史的資料

第2章 至2021年的收益預測、成長率、年複合成長率

第3章 產業分析

第4章 競爭分析

第5章 各地區成長資料

  • 簡介
  • 市場概要
    • 市場定義和範圍
    • 主要調查結果
    • 指標分析
    • 主要市場概要
    • 競爭情報
    • 價值鏈分析
    • 主要的購買標準
    • 策略性建議
    • 策略性結論
  • 市場決策因素
    • 推動市場的要素
    • 阻礙市場的要素
    • 市場課題
    • 市場機會
  • 部門分析
  • 主力品牌
  • 市場區隔
    • 全球眼科設備市場
      • 眼科診斷、監測設備
      • 眼科手術設備
    • 全球眼科藥物市場
      • 藥物遞輸
      • 青光眼
      • 視網膜疾病
      • 乾眼症
      • 過敏性結膜炎、發炎、結膜炎
  • 各治療市場
  • 各終端用戶市場
  • 競爭環境
    • 市場佔有率
    • 策略
  • 各地區分析
    • 北美
    • 歐洲
    • 亞太地區
    • 其他
  • 企業簡介

圖表

目錄
Product Code: HPH-1601015

The global ophthalmology drugs and devices market is expected to grow at a CAGR of 7% for the forecasted period of 2015-2021. The market was worth $XX billion in 2014 and is expected to be $XX billion in 2021. The market is driven by various factors which include increase prevalence of eye related disorders such as glaucoma and cataract aging population, regulatory approvals to new drugs and devices, new technologies such as minimally invasive surgical devices, focus on combining drugs and device therapies and increasing economic factors such as rise in disposable income and health expenditure. The market opportunities lie in the growing awareness especially in the emerging and underdeveloped countries, demand for intraocular lenses, phacoemulsification devices and other devices and therapies. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hamper the market growth.

The market is segmented on the basis of ophthalmic diagnostic & monitoring equipment market which includes optical coherence tomography scanners market, ultra sound imaging systems, fundus camera market, ophthalmoscopes, retinoscope and other market. The surgical devices include cataract surgery device, intraocular lens market, phacoemulsification devices, glaucoma surgery device market and others. The popular drugs include Lucentis, Eylea, Avastin, Restasis, Lumigan and Ganfort, Xalatan/Xalacom, Pataday and other. The drugs include drugs for glaucoma, retinal disorder, dry eye, allergic conjunctivitis, inflammation and conjunctivitis. The end users include hospitals, eye clinics, diagnostic centres and patients.

The major geographies include North America, Europe, Asia-Pacific and rest of the world. North America is the largest market followed by Europe and Asia pacific. The North American market is driven high awareness, availability of drugs and devices, better regulatory outreach which leads to increased trust in the devices and drugs. Asia Pacific market to have high growth rate driven by strong markets in China and India. Market includes top players such as Abbot Laboratories, Alcon Inc, Ellex Medical lasers ltd, Essilor international S.A., Allergan Inc, Bausch & Lomb Inc, Carl Zeiss Meditec AG, Johnson and Johnson and Hoya Corporation.

  • 1. Abbot Laboratories
  • 2. Alcon Inc
  • 3. Ellex Medical lasers ltd
  • 4. Essilor international S.A.
  • 5. Allergan Inc
  • 6. Bausch & Lomb Inc
  • 7. Carl Zeiss Meditec AG
  • 8. Johnson and Johnson
  • 9. Hoya corporation
  • 10. Pfizer Inc
  • 11. Roche holding AG
  • 12. Santen pharmaceutical co. ltd
  • 13. Staar surgical company
  • 14. Iridex corporation
  • 15. Merc & Co. Inc
  • 16. Nidek Co. Ltd
  • 17. Topcon corporation
  • 18. Novagali Pharma S.A.
  • 19. Novartis AG
  • 20. Nicox
  • 21. Acucela
  • 22. Senju
  • 23. Bayer
  • 24. Valeant
  • 25. Regeneron
  • 26. Akorn
  • 27. Eyemed
  • 28. Visioncare ophthalmic technologies
  • 29. Biotech Visioncare
  • 30. VSP

Table of Contents

This Occams Research Report covers

1. Historical data

2. Revenue forecasts, growth rates and CAGR up to 2021

3. Industry Analysis

4. Competitive Analysis

5. Key geographic growth data

  • 1. Introduction
    • 1.1. Executive summary
    • 1.2. Estimation methodology
  • 2. Market overview
    • 2.1. Market definition and scope
    • 2.2. Key findings
    • 2.3. Parametric analysis
      • 2.3.1. Prevalence & incidence rate of eye disorders
      • 2.3.2. Hospital and eye clinic across geographies
      • 2.3.3. Increasing cataract surgeries
      • 2.3.4. Healthcare expenditure across geographies
      • 2.3.5. Disposable income of top emerging economies
    • 2.4. Key market insights
      • 2.4.1. Top 3 emerging countries
      • 2.4.2. Top 3 revenue generating segments
      • 2.4.3. Top growing markets and emerging trends
      • 2.4.4. Pipeline analysis
        • 2.4.4.1. SHP616:acute neuromyelitis optica
        • 2.4.4.2. SHP622: friedreich's ataxia
        • 2.4.4.3. SHP606: dry eye disease
        • 2.4.4.4. Lifitegrast: dry eye disease
        • 2.4.4.5. SHP626: non alcoholic steatohepatitis
        • 2.4.4.6. SHP627: focal segmental glomerulosclerosis
        • 2.4.4.7. Guanfacine: (EU) ADHD
        • 2.4.4.8. MIM-D3: dry eye disease
        • 2.4.4.9. EGP-437: dry eye disease
        • 2.4.4.10. EBI-005: dry eye disease
        • 2.4.4.11. RU-101: dry eye disease
        • 2.4.4.12. OTX-DP: dry eye disease
      • 2.4.5. R&D scenario in ophthalmology market
        • 2.4.5.1. Plasma technology in ophthalmology
        • 2.4.5.2. Cornial topography & cornial analysis
        • 2.4.5.3. Scope of virtual reality technology in eye care
    • 2.5. Competitive intelligence
      • 2.5.1. Market share analysis
      • 2.5.2. Top winning strategies
      • 2.5.3. Case studies: top competitive moves
    • 2.6. Value chain analysis
    • 2.7. Key buying criteria
    • 2.8. Strategic recommendation
    • 2.9. Strategic conclusions
  • 3. Market determinants
    • 3.1. Market drivers
      • 3.1.1. FDA approvals giving rise to adoption of drugs and devices
      • 3.1.2. Global increase in elderly population giving rise to ophthalmology market
      • 3.1.3. Technological advancement
      • 3.1.4. Innovation giving rise to ophthalmology drug and device market
      • 3.1.5. Global increase in prevalence rates of eye diseases
      • 3.1.6. Global increase in adoption of ophthalmology therapies and drugs
      • 3.1.7. Global increase in healthcare expenditure
      • 3.1.8. Global increase in minimally invasive surgeries
      • 3.1.9. High prevalence rates of refractive errors driving the surgeries in ophthalmology market
    • 3.2. Market restraints
      • 3.2.1. Major drugs going off patent is affecting the growth of ophthalmology market
      • 3.2.2. Drying pipelines is a concern for major players
    • 3.3. Market challenges
      • 3.3.1. Risk associated with the ocular diseases
      • 3.3.2. Creating awareness for ophthalmology drug and device market
      • 3.3.3. Global economic slowdown may affect the ophthalmology drug and device market
    • 3.4. Market opportunities
      • 3.4.1. Intraocular lenses, phacoemulsification devices and increasing cataract surgeries to create opportunities in emerging economies
      • 3.4.2. Untapped APAC region has huge scope for ophthalmology drug and device market
      • 3.4.3. Increase in diabetic retinopathies rising the demand for vitreoretinal surgeries
  • 4. Sector Analysis
    • 4.1. Parent market
    • 4.2. Sub-segment market
    • 4.3. Alternative market
  • 5. Top ophthalmic drugs brands
    • 5.1. Lucentis
    • 5.2. Eylea
    • 5.3. Avastin
    • 5.4. Restasis
    • 5.5. Lumigan and Ganfort
    • 5.6. Xalatan/Xalacom
    • 5.7. Travatan/Travatan Z and DuoTrav
    • 5.8. Alphagan/Alphagan P and Combigan
    • 5.9. Vigamox
    • 5.10. Pataday
    • 5.11. Refresh brand products
    • 5.12. Tapros
    • 5.13. Cosopt
  • 6. Market Segmentation
    • 6.1. Global ophthalmology device market
      • 6.1.1. Global ophthalmic diagnostic & monitoring equipment market, 2014-2021,($ millions)
        • 6.1.1.1. Global optical coherence tomography scanners market, 2014-2021,($ millions)
        • 6.1.1.2. Global ophthalmic ultra sound imaging systems market, 2014-2021,($ millions)
        • 6.1.1.3. Global fundus camera market, 2014-2021,($ millions)
        • 6.1.1.4. Global ophthal moscopes, 2014-2021,($ millions)
        • 6.1.1.5. Global retinoscope market , 2014-2021,($ millions)
        • 6.1.1.6. Global pachymeter market, 2014-2021,($ millions)
        • 6.1.1.7. Global wavefront aberrometers market , 2014-2021,($ millions)
        • 6.1.1.8. Global perimeters/visual field analyzer market s, 2014-2021,($ millions)
        • 6.1.1.9. Global autorefractors/phoropter market, 2014-2021,($ millions)
        • 6.1.1.10. Global keratometers, 2014-2021 market,($ millions)
        • 6.1.1.11. Global specular microscope market, 2014-2021,($ millions)
        • 6.1.1.12. Global corneal topoghaphers market, 2014-2021,($ millions)
        • 6.1.1.13. Global tonometers market, 2014-2021,($ millions)
        • 6.1.1.14. Global slit lamps market , 2014-2021,($ millions)
        • 6.1.1.15. Global bio meters market, 2014-2021,($ millions)
        • 6.1.1.16. Global other market, 2014-2021,($ millions)
      • 6.1.2. Global ophthalmology surgery device market , 2014-2021,($ millions)
        • 6.1.2.1. Global cataract surgery device market , 2014-2021,($ millions)
          • 6.1.2.1.1. Global intraocular lens market, 2014-2021,($ millions)
          • 6.1.2.1.2. Global phacoemulsification devices market, 2014-2021,($ millions)
          • 6.1.2.1.3. Global ophthalmic Viscoelastic devices market, 2014-2021,($ millions)
        • 6.1.2.2. Global glaucoma surgery device market, 2014-2021,($ millions)
          • 6.1.2.2.1. Global stents and implant market, 2014-2021,($ millions)
          • 6.1.2.2.2. Global glaucoma drainage device market, 2014-2021,($ millions)
          • 6.1.2.2.3. Global glaucoma system market, 2014-2021,($ millions)
          • 6.1.2.2.4. Global glaucoma laser market , 2014-2021,($ millions)
        • 6.1.2.3. Global refractive surgery device market, 2014-2021,($ millions)
          • 6.1.2.3.1. Global excimer laser market, 2014-2021,($ millions)
          • 6.1.2.3.2. Global emcrokeratome market, 2014-2021,($ millions)
          • 6.1.2.3.3. Global femtosecond laser market, 2014-2021,($ millions)
          • 6.1.2.3.4. Global yag laser market, 2014-2021,($ millions)
        • 6.1.2.4. Global vitreoretinal surgery device market , 2014-2021,($ millions)
          • 6.1.2.4.1. Global photocoagulation laser market, 2014-2021,($ millions)
          • 6.1.2.4.2. Global illumination device market, 2014-2021,($ millions)
          • 6.1.2.4.3. Global vitrectomy machine market, 2014-2021,($ millions)
        • 6.1.2.5. Global visioncare market , 2014-2021,($ millions)
          • 6.1.2.5.1. Global contact lens market , 2014-2021,($ millions)
          • 6.1.2.5.2. Global spectacles market, 2014-2021,($ millions)
    • 6.2. Global ophthalmology drug market , 2014-2021,($ millions)
      • 6.2.1. Global drug delivery types , 2014-2021,($ millions)
        • 6.2.1.1. Global eye drops market , 2014-2021,($ millions)
        • 6.2.1.2. Global capsules & tablet market, 2014-2021,($ millions)
        • 6.2.1.3. Global eye ointment market, 2014-2021,($ millions)
        • 6.2.1.4. Global gel market , 2014-2021,($ millions)
        • 6.2.1.5. Global eye solution market , 2014-2021,($ millions)
      • 6.2.2. Glaucoma
        • 6.2.2.1. Xalatan (Latanoprost)/Xalacom (Latanoprost and Timolol combination) (Xalabrands)
        • 6.2.2.2. Lumigan franchise [Lumigan (Bimatoprost) + Ganfort (Bimatoprost and Timolol combination)]
        • 6.2.2.3. Tapros/Taflotan (Tafluprost)
        • 6.2.2.4. Saflutan/Zioptan (Tafluprost)
        • 6.2.2.5. Alphagan (Brimonidine)/Combigan (Brimonidine and Timolol combination)
        • 6.2.2.6. Cosopt (Dorzolamide and Timolol combination)/ Trusopt (Dorzolamide)
        • 6.2.2.7. Azarga (Brinzolamide and Timolol combination)
        • 6.2.2.8. Azopt (Brinzolamide)
      • 6.2.3. Global retinal disorder market , 2014-2021,($ millions)
        • 6.2.3.1. Lucentis (Ranibizumab)
        • 6.2.3.2. Visudyne (Verteporfin)
        • 6.2.3.3. Avastin (Bevacizumab)
        • 6.2.3.4. Eylea (Aflibercept)
      • 6.2.4. Dry eye
        • 6.2.4.1. Restasis (Cyclosporine)
        • 6.2.4.2. Hyalein (Sodium hyaluronate)
        • 6.2.4.3. Diquas (Diquafosol sodium)
      • 6.2.5. Allergic conjunctivitis, inflammation and conjunctivitis
        • 6.2.5.1. Patanol/Pataday/Opatanol (Olopatadine)
        • 6.2.5.2. Bepreve (Bepotastine besilate)
        • 6.2.5.3. TobraDex (Tobramycin & Dexamethasone combination)
        • 6.2.5.4. Xibrom/Bromday (Bromfenac)
        • 6.2.5.5. Vigamox (Moxifloxacin)
        • 6.2.5.6. AzaSite (Azithromycin)
    • 6.3. Global ophthalmology drug and device market by therapeutics , 2014-2021,($ millions)
      • 6.3.1. Global diabetic macular edema market, 2014-2021,($ millions)
      • 6.3.2. Global eye cancer market, 2014-2021,($ millions)
      • 6.3.3. Global diabetic retinopathy market, 2014-2021,($ millions)
      • 6.3.4. Global retinal vein occlusion market, 2014-2021,($ millions)
      • 6.3.5. Global age-related macular degeneration market, 2014-2021,($ millions)
      • 6.3.6. Global conjunctivitis market, 2014-2021,($ millions)
      • 6.3.7. Global dry eye market, 2014-2021,($ millions)
      • 6.3.8. Global glaucoma market, 2014-2021,($ millions)
      • 6.3.9. Global keratitis market, 2014-2021,($ millions)
      • 6.3.10. Global lens opacification and intraocular lens market, 2014-2021,($ millions)
      • 6.3.11. Global geographic atrophy market, 2014-2021,($ millions)
    • 6.4. Global ophthalmology drug and device market by end user, 2014-2021,($ millions)
      • 6.4.1. Hospitals
      • 6.4.2. Eye clinics
      • 6.4.3. Diagnostic centers
      • 6.4.4. Patients
  • 7. Competitive Landscape
    • 7.1. Market share
    • 7.2. Strategy - An analysis across tiers
  • 8. Geographical analysis
    • 8.1. North America market, 2014-2021,($ million)
      • 8.1.1. United States (U.S.) market, 2014-2021,($ million)
      • 8.1.2. Canada market, 2014-2021,($ million)
    • 8.2. Europe market, 2014-2021,($ million)
      • 8.2.1. United Kingdom (UK) market, 2014-2021,($ million)
      • 8.2.2. France market, 2014-2021,($ million)
      • 8.2.3. Germany market, 2014-2021,($ million)
      • 8.2.4. Spain market, 2014-2021,($ million)
      • 8.2.5. Italy market, 2014-2021,($ million)
      • 8.2.6. RoE market, 2014-2021,($ million)
    • 8.3. Asia Pacific market, 2014-2021,($ million)
      • 8.3.1. India market, 2014-2021,($ million)
      • 8.3.2. China market, 2014-2021,($ million)
      • 8.3.3. Japan market, 2014-2021,($ million)
      • 8.3.4. Korea market, 2014-2021,($ million)
      • 8.3.5. Australia market, 2014-2021,($ million)
      • 8.3.6. RoAPAC market, 2014-2021,($ million)
    • 8.4. Rest of the world market, 2014-2021,($ million)
      • 8.4.1. Latin America market, 2014-2021,($ million)
      • 8.4.2. MENA market, 2014-2021,($ million)
      • 8.4.3. Africa market, 2014-2021,($ million)
  • 9. Company Profiling: - (Over, SCOT analysis, strategic review)
    • 9.1. Abbot Laboratories
    • 9.2. Alcon Inc
    • 9.3. Ellex Medical lasers ltd
    • 9.4. Essilor international S.A.
    • 9.5. Allergan Inc
    • 9.6. Bausch & Lomb Inc
    • 9.7. Carl Zeiss Meditec AG
    • 9.8. Johnson and Johnson
    • 9.9. Hoya corporation
    • 9.10. Pfizer Inc
    • 9.11. Roche holding AG
    • 9.12. Santen pharmaceutical co. ltd
    • 9.13. Staar surgical company
    • 9.14. Iridex corporation
    • 9.15. Merc & Co. Inc
    • 9.16. Nidek Co. Ltd
    • 9.17. Topcon corporation
    • 9.18. Novagali Pharma S.A.
    • 9.19. Novartis AG
    • 9.20. Nicox
    • 9.21. Acucela
    • 9.22. Senju
    • 9.23. Bayer
    • 9.24. Valeant
    • 9.25. Regeneron
    • 9.26. Akorn
    • 9.27. Eyemed
    • 9.28. Visioncare ophthalmic technologies
    • 9.29. Biotech Visioncare
    • 9.30. VSP

List of Tables

  • 1. Global ophthalmology device market, 2014-2021, ($ millions)
  • 2. Global ophthalmic diagnostic & monitoring equipment market, 2014-2021, ($ millions)
  • 3. Global optical coherence tomography scanners market, 2014-2021,($ millions)
  • 4. Global ophthalmic ultra sound imaging systems market, 2014-2021,($ millions)
  • 5. Global fundus camera market, 2014-2021,($ millions)
  • 6. Global ophthalmoscopes, 2014-2021,($ millions)
  • 7. Global retinoscope market , 2014-2021,($ millions)
  • 8. Global pachymeter market, 2014-2021,($ millions)
  • 9. Global wavefront aberrometers market , 2014-2021,($ millions)
  • 10. Global perimeters/visual field analyzer market s, 2014-2021,($ millions)
  • 11. Global autorefractors/phoropter market, 2014-2021,($ millions)
  • 12. Global keratometers, 2014-2021 market,($ millions)
  • 13. Global specular microscope market, 2014-2021,($ millions)
  • 14. Global corneal topoghaphers market, 2014-2021,($ millions)
  • 15. Global tonometers market, 2014-2021,($ millions)
  • 16. Global slit lamps market , 2014-2021,($ millions)
  • 17. Global bio meters market, 2014-2021,($ millions)
  • 18. Global other market, 2014-2021,($ millions)
  • 19. Global ophthalmology surgery device market , 2014-2021,($ millions)
  • 20. Global cataract surgery device market , 2014-2021,($ millions)
  • 21. Global intraocular lens market, 2014-2021,($ millions)
  • 22. Global phacoemulsification devices market, 2014-2021,($ millions)
  • 23. Global ophthalmic Viscoelastic devices market, 2014-2021,($ millions)
  • 24. Global glaucoma surgery device market, 2014-2021,($ millions)
  • 25. Global stents and implant market, 2014-2021,($ millions)
  • 26. Global glaucoma drainage device market, 2014-2021,($ millions)
  • 27. Global glaucoma system market, 2014-2021,($ millions)
  • 28. Global glaucoma laser market , 2014-2021,($ millions)
  • 29. Global refractive surgery device market, 2014-2021,($ millions)
  • 30. Global excimer laser market, 2014-2021,($ millions)
  • 31. Global emcrokeratome market, 2014-2021,($ millions)
  • 32. Global femtosecond laser market, 2014-2021,($ millions)
  • 33. Global yag laser market, 2014-2021,($ millions)
  • 34. Global vitreoretinal surgery device market , 2014-2021,($ millions)
  • 35. Global photocoagulation laser market, 2014-2021,($ millions)
  • 36. Global illumination device market, 2014-2021,($ millions)
  • 37. Global vitrectomy machine market, 2014-2021,($ millions)
  • 38. Global visioncare market , 2014-2021,($ millions)
  • 39. Global contact lens market , 2014-2021,($ millions)
  • 40. Global spectacles market, 2014-2021,($ millions)
  • 41. Global ophthalmology drug and device market by therapeutics , 2014-2021,($ millions)
  • 42. Global diabetic macular edema market, 2014-2021,($ millions)
  • 43. Global eye cancer market, 2014-2021,($ millions)
  • 44. Global diabetic retinopathy market, 2014-2021,($ millions)
  • 45. Global retinal vein occlusion market, 2014-2021,($ millions)
  • 46. Global age-related macular degeneration market, 2014-2021,($ millions)
  • 47. Global conjunctivitis market, 2014-2021,($ millions)
  • 48. Global dry eye market, 2014-2021,($ millions)
  • 49. Global glaucoma market, 2014-2021,($ millions)
  • 50. Global keratitis market, 2014-2021,($ millions)
  • 51. Global lens opacification and intraocular lens market, 2014-2021,($ millions)
  • 52. Global geographic atrophy market, 2014-2021,($ millions)
  • 53. Global ophthalmology drug market, 2014-2021, ($ millions)
  • 54. Global drug delivery types, 2014-2021, ($ millions)
  • 55. Global eye drops market, 2014-2021, ($ millions)
  • 56. Global capsules & tablet market, 2014-2021, ($ millions)
  • 57. Global eye ointment market, 2014-2021, ($ millions)
  • 58. Global gel market, 2014-2021, ($ millions)
  • 59. Global eye solution market, 2014-2021, ($ millions)
  • 60. Global retinal disorder market, 2014-2021, ($ millions)
  • 61. Global ophthalmology drug and device market by end user, 2014-2021, ($ millions)
  • 62. Global ophthalmology market by hospitals, 2014-2021, ($ millions)
  • 63. Global ophthalmology market by eye clinics, 2014-2021, ($ millions)
  • 64. Global ophthalmology market by diagnostic centers, 2014-2021, ($ millions)
  • 65. Global ophthalmology market by patients, 2014-2021, ($ millions)

List of figure:

  • 1. United States (U.S.) market, 2014-2021,($ million)
  • 2. Canada market, 2014-2021,($ million)
  • 3. United Kingdom (UK) market, 2014-2021,($ million)
  • 4. France market, 2014-2021,($ million)
  • 5. Germany market, 2014-2021,($ million)
  • 6. Spain market, 2014-2021,($ million)
  • 7. Italy market, 2014-2021,($ million)
  • 8. RoE market, 2014-2021,($ million)
  • 9. India market, 2014-2021,($ million)
  • 10. China market, 2014-2021,($ million)
  • 11. Japan market, 2014-2021,($ million)
  • 12. Korea market, 2014-2021,($ million)
  • 13. Australia market, 2014-2021,($ million)
  • 14. RoAPAC market, 2014-2021,($ million)
  • 15. Latin America market, 2014-2021,($ million)
  • 16. MENA market, 2014-2021,($ million)
  • 17. Africa market, 2014-2021,($ million)
Back to Top